More insight into the mode of action of lipophilic antitumor drugs containing a platinum (II) fragment
Journal Title: Journal of Medical Biomedical and Applied Sciences - Year 2017, Vol 5, Issue 3
Abstract
Cis-Diammine (1,1-cyclobutanedicarboxylato) platinum (II)) (Carboplatin 2) is a second generation platinum anticancer drug following Cis-diammine dichloro platinum (II) (Cisplatin 1). In the present study Cisplatin and Carboplatin analogs are attached to the acid group of the bile acid via an ester link called as ChAPt (n) Cis and ChAPt (n) Carbo. The in vitro antitumor activity of Cisplatin 1 long with the corresponding ChAPt derivatives evaluated against a panel of five tumor cell lines of different histogenic origin. A series of biological methods starting from Sulforhodamine B (SRB) assay to determine IC50, Cell cycle analysis, Annexin Vassay and Caspase assays were performed with the aim to scrutinize the anticancer mode of action on HepG2 (hepatocellular carcinoma) cell line. The compounds exerted a dose dependent antiproliferative action at micromolar concentrations and the effect of these structural variations on anticancer activity was elaborated and discussed more in detail. To summarize, several compounds revealed significant antitumor activity and surprisingly the ChAPt (11) Cis and ChAPt(11)Carbo induce programmed cell death with molecular features different from each other, suggesting that both drugs induce apoptosis through different initial pathways.
Authors and Affiliations
Kranthi Vanchanagiri Sebastian Paschke, Thomas Mueller, Hans-Joachim Schmoll
Keywords
Related Articles
- EP ID EP312959
- DOI 10.15520/.v5i3.54
- Views 84
- Downloads 0
ORAL CHANGES AFTER RADIOTHERAPY IN PATIENTS WITH HEAD AND NECK CANCER
Cancer of the mouth begins in the oral cavity which includes: lips, jugal mucosa, teeth, gums, the first two-thirds of the tongue, floor of mouth, hard palate and retromolar trigone. Radiation therapy is a method capable...
ABO BLOOD TYPE AND THREAT OF GIT CANCER AND LIVER CANCER IN BANGLADESHI POPULATIONS
Background: The prognosis of several malignancies is associated with blood groups ABOs, however, the mechanisms still remain unknown. The study was designed to explore the possible association among the esophageal cancer...
Bleeding feature in the Hematology department in Brazzaville, Congo
Background: Epidemiological and clinical characteristics data of patients with bleeding symptoms are unknown. Methods: a total of 6961 medical records of patients admitted in the hematology department in a teaching hospi...
CORRELATION AMONG INHIBIN A AND B, ANTI-MU¨ LLERIAN HORMONE, FOLLICLE-STIMULATING HORMONE, LUTEINIZING HORMONE, AND ESTRADIOL HORMONES IN INFERTILE WOMEN
Objective: The main purpose of this study was to assess ovarian reserve in infertile women and whether hormonal status depends on anti-M¨ ullerian hormone level. Study Design: This retrospective study evaluated and compa...
PHENOTYPIC SPECTRUM AND AGE DISTRIBUTION OF SLC25A4 MUTATIONS
see the pdf